Report Categories
View AllRecent Articles
View All
DFIN Donnelley notches 673 percent EPS upside in Q4 2025 while shares dip 16 percent in todays trading
AbbVie Inc ABBV Former Senior Immunology RD Leader Anthony Slavin Appointed SVP of Portfolio Strategy at Infinimmune
WMB Williams reports 16 percent Q1 2026 EPS surprise shares rise 19 percent on positive investor reaction
What top holdings BioXcel BTAI Mini Selloff 20260429